128 related articles for article (PubMed ID: 25497224)
1. Expression and characterization of myristoylated preS1-conjugated nanocages for targeted cell delivery.
Murata M; Piao JS; Narahara S; Kawano T; Hamano N; Kang JH; Asai D; Ugawa R; Hashizume M
Protein Expr Purif; 2015 Jun; 110():52-6. PubMed ID: 25497224
[TBL] [Abstract][Full Text] [Related]
2. Bacterial expression, purification, and in vitro N-myristoylation of fusion hepatitis B virus preS1 with the native-type N-terminus.
Ma HH; Yang L; Yang XY; Xu ZP; Li BL
Protein Expr Purif; 2003 Jan; 27(1):49-54. PubMed ID: 12509984
[TBL] [Abstract][Full Text] [Related]
3. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus.
Bremer CM; Sominskaya I; Skrastina D; Pumpens P; El Wahed AA; Beutling U; Frank R; Fritz HJ; Hunsmann G; Gerlich WH; Glebe D
J Hepatol; 2011 Jul; 55(1):29-37. PubMed ID: 21145866
[TBL] [Abstract][Full Text] [Related]
4. Expression and characterization of the preS1 peptide of hepatitis B surface antigen in Escherichia coli.
Lin Y; Liu YX; Cislo T; Mason BL; Yu MY
J Med Virol; 1991 Mar; 33(3):181-7. PubMed ID: 1880495
[TBL] [Abstract][Full Text] [Related]
5. Purification and structural analysis of the hepatitis B virus preS1 expressed from Escherichia coli.
Maeng CY; Oh MS; Park IH; Hong HJ
Biochem Biophys Res Commun; 2001 Apr; 282(3):787-92. PubMed ID: 11401532
[TBL] [Abstract][Full Text] [Related]
6. A C-terminal PreS1 sequence is sufficient to retain hepatitis B virus L protein in 293 cells.
Gallina A; Gazina E; Milanesi G
Virology; 1995 Oct; 213(1):57-69. PubMed ID: 7483279
[TBL] [Abstract][Full Text] [Related]
7. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes.
Glebe D; Urban S; Knoop EV; Cag N; Krass P; Grün S; Bulavaite A; Sasnauskas K; Gerlich WH
Gastroenterology; 2005 Jul; 129(1):234-45. PubMed ID: 16012950
[TBL] [Abstract][Full Text] [Related]
8. Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes.
Meier A; Mehrle S; Weiss TS; Mier W; Urban S
Hepatology; 2013 Jul; 58(1):31-42. PubMed ID: 23213046
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a hepatitis B and hepatitis delta virus receptor binding site.
Engelke M; Mills K; Seitz S; Simon P; Gripon P; Schnölzer M; Urban S
Hepatology; 2006 Apr; 43(4):750-60. PubMed ID: 16557545
[TBL] [Abstract][Full Text] [Related]
10. A safe and efficient hepatocyte-selective carrier system based on myristoylated preS1/21-47 domain of hepatitis B virus.
Zhang Q; Zhang X; Chen T; Wang X; Fu Y; Jin Y; Sun X; Gong T; Zhang Z
Nanoscale; 2015; 7(20):9298-310. PubMed ID: 25945919
[TBL] [Abstract][Full Text] [Related]
11. Expression of the PreS1 peptide of hepatitis B virus and preparation of its polyclonal antibody.
Chen W; Zhang J; Zhang J; Wang D; Li Y; Huang A
Hybridoma (Larchmt); 2011 Dec; 30(6):525-30. PubMed ID: 22149277
[TBL] [Abstract][Full Text] [Related]
12. A modified hepatitis B virus surface antigen with the receptor-binding site for hepatocytes at its C terminus: expression, antigenicity and immunogenicity.
Xu X; Li GD; Kong YY; Yang HL; Zhang Z; Cao HT; Wang Y
J Gen Virol; 1994 Dec; 75 ( Pt 12)():3673-7. PubMed ID: 7527840
[TBL] [Abstract][Full Text] [Related]
13. Expression and purification of the synthetic preS1 gene of Hepatitis B Virus with preferred Escherichia coli codon preference.
Qian B; Shen H; Xiong J; Chen L; Zhang L; Jia J; Wang Y; Zhang Z; Yuan Z; Cao K; Zhang D
Protein Expr Purif; 2006 Jul; 48(1):74-80. PubMed ID: 16439156
[TBL] [Abstract][Full Text] [Related]
14. High level expression of hepatitis B virus preS1 peptide in Escherichia coli.
Rhyum SB; Jin BR; Park HR; Hong HJ
J Biotechnol; 1994 Aug; 36(3):221-30. PubMed ID: 7765264
[TBL] [Abstract][Full Text] [Related]
15. Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide.
Argnani R; Boccafogli L; Marconi PC; Manservigi R
Gene Ther; 2004 Jul; 11(13):1087-98. PubMed ID: 15057264
[TBL] [Abstract][Full Text] [Related]
16. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein.
Gripon P; Cannie I; Urban S
J Virol; 2005 Feb; 79(3):1613-22. PubMed ID: 15650187
[TBL] [Abstract][Full Text] [Related]
17. Liver cell specific targeting by the preS1 domain of hepatitis B virus surface antigen displayed on protein nanocages.
Murata M; Narahara S; Umezaki K; Toita R; Tabata S; Piao JS; Abe K; Kang JH; Ohuchida K; Cui L; Hashizume M
Int J Nanomedicine; 2012; 7():4353-62. PubMed ID: 22927755
[TBL] [Abstract][Full Text] [Related]
18. Expression and characterization of hepatitis C Virus E2 glycoprotein fused to hepatitis B virus preS1(21-47) fragment in CHO cells.
Wang CL; Zhu LX; Liu J; Zhang ZC; Wang Y; Li GD
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Jul; 34(4):400-4. PubMed ID: 12098759
[TBL] [Abstract][Full Text] [Related]
19. Liver cell-specific peptides derived from the preS1 domain of human hepatitis B virus.
Kang JH; Toita R; Asai D; Yamaoka T; Murata M
J Virol Methods; 2014 Jun; 201():20-3. PubMed ID: 24568971
[TBL] [Abstract][Full Text] [Related]
20. N-terminal myristylation of HBV preS1 domain enhances receptor recognition.
De Falco S; Ruvo M; Verdoliva A; Scarallo A; Raimondo D; Raucci A; Fassina G
J Pept Res; 2001 May; 57(5):390-400. PubMed ID: 11350599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
